Dysphagia Prevalence and Outcomes Associated with the Evolution of COVID-19 and Its Variants in Critically Ill Patients

被引:4
|
作者
Clayton, Nicola A. [1 ,2 ,3 ,4 ]
Freeman-Sanderson, Amy [5 ,6 ,7 ,8 ,9 ]
Walker, Elizabeth [9 ]
机构
[1] Concord Repatriat Gen Hosp, Speech Pathol Dept, Bldg 42,Hosp Rd, Sydney, NSW 2139, Australia
[2] Concord Repatriat Gen Hosp, Intens Care Unit, Bldg 42,Hosp Rd, Sydney, NSW 2139, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[4] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia
[5] Royal Prince Alfred Hosp, Speech Pathol Dept, Sydney, NSW, Australia
[6] Royal Prince Alfred Hosp, Intens Care Unit, Sydney, NSW, Australia
[7] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia
[8] George Inst Global Hlth, Crit Care Div, Sydney, NSW, Australia
[9] Monash Univ, Australian & New Zealand Intens Care Res Ctr ANZIC, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
关键词
COVID-19; SARS-CoV2; Dysphagia; Critically ill; Recovery; SCALE; COORDINATION; SURVIVORS; SEVERITY;
D O I
10.1007/s00455-023-10598-7
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Data collected during the 2020-21 COVID-19 alpha wave indicated dysphagia prevalence rates up to 93%. Whilst many patients recovered during hospital admission, some experienced persistent dysphagia with protracted recovery. To explore (1) prevalence, (2) treatment, and (3) recovery patterns and outcomes for swallowing, in the ICU patient with Delta and subsequent variants of COVID-19. Prospective observational study. Patients admitted to 26 Intensive Care Units (ICUs) over 12 months, diagnosed with COVID-19, treated for survival and seen by Speech-Language Pathology (SLP) for clinical swallowing assessment were included. Demographic, medical, SLP treatment, and swallowing outcome data were collected. 235 participants (63% male, median age = 58 years) were recruited. Median mechanical ventilation was 16 days, and ICU and hospital length of stay (LOS) were 20 and 42 days, respectively. ICU-Acquired Weakness (54%) and delirium (49%) were frequently observed. Prevalence of dysphagia was 94% with the majority (45%) exhibiting profound dysphagia (Functional Oral Intake Scale = 1) at initial assessment. Median duration to initiate oral feeding was 19 days (IQR = 11-44 days) from ICU admission, and 24% received dysphagia rehabilitation. Dysphagia recovery by hospital discharge was observed in 71% (median duration = 30 days [IQR = 17-56 days]). Positive linear associations were identified between duration of intubation, mechanical ventilation, hospital and ICU LOS, and duration to SLP assessment (p = 0.000), dysphagia severity (p = 0.000), commencing oral intake (p = 0.000), dysphagia recovery (p < 0.01), and enteral feeding (p = 0.000). Whilst older participants had more severe dysphagia (p = 0.028), younger participants took longer to commence oral feeding (p = 0.047). Dysphagia remains highly prevalent in ICU COVID-19 patients. Whilst invasive ventilation duration is associated with swallowing outcomes, more evidence on dysphagia pathophysiology is required to guide rehabilitation.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 50 条
  • [31] Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients
    Wozniak, Hannah
    Le Terrier, Christophe
    Primmaz, Steve
    Suh, Noemie
    Lenglet, Sebastien
    Thomas, Aurelien
    Vuilleumier, Nicolas
    Pagano, Sabrina
    de Watteville, Aude
    Stringhini, Silvia
    Guessous, Idris
    Quintard, Herve
    Heidegger, Claudia Paula
    Pugin, Jerome
    NUTRIENTS, 2023, 15 (15)
  • [32] Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study
    Ferreira, Juliana C.
    Ho, Yeh-Li
    Besen, Bruno Adler Maccagnan Pinheiro
    Malbouisson, Luiz Marcelo Sa
    Taniguchi, Leandro Utino
    Mendes, Pedro Vitale
    Costa, Eduardo Leite Vieira
    Park, Marcelo
    Daltro-Oliveira, Renato
    Roepke, Roberta M. L.
    Silva-Jr, Joao M.
    Carmona, Maria Jose Carvalho
    Carvalho, Carlos R. R.
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)
  • [33] Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia
    Bahloul, Mabrouk
    Kharrat, Sana
    Chtara, Kamilia
    Hafdhi, Malek
    Turki, Olfa
    Baccouche, Najeh
    Ammar, Rania
    Kallel, Nozha
    Hsairi, Majdi
    Chakroun-Walha, Olfa
    Ben Hamida, Chokri
    Chelly, Hedi
    Ben Mahfoudh, Khaiereddine
    Karoui, Abelhamid
    Karray, Hela
    Rekik, Noureddine
    Bouaziz, Mounir
    ACUTE AND CRITICAL CARE, 2022, 37 (01) : 84 - 93
  • [34] Secondary pneumonias in critically ill patients with COVID-19: risk factors and outcomes
    Povoa, Pedro
    Martin-Loeches, Ignacio
    Nseir, Saad
    CURRENT OPINION IN CRITICAL CARE, 2021, 27 (05) : 468 - 473
  • [35] Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19
    Yoon, Si Mong
    Lee, Jinwoo
    Lee, Sang-Min
    Lee, Hong Yeul
    FRONTIERS IN MEDICINE, 2023, 10
  • [36] Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study
    Juliana C. Ferreira
    Yeh-Li Ho
    Bruno Adler Maccagnan Pinheiro Besen
    Luiz Marcelo Sa Malbouisson
    Leandro Utino Taniguchi
    Pedro Vitale Mendes
    Eduardo Leite Vieira Costa
    Marcelo Park
    Renato Daltro-Oliveira
    Roberta M. L. Roepke
    Joao M. Silva-Jr
    Maria Jose Carvalho Carmona
    Carlos R. R. Carvalho
    Annals of Intensive Care, 11
  • [37] Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients
    Sun, Chaoyang
    Sun, Yuzhe
    Wu, Ping
    Ding, Wencheng
    Wang, Shiyou
    Li, Jiafeng
    Liang, Langchao
    Chai, Chaochao
    Fu, Yu
    Li, Zhiming
    Zhu, Linnan
    Ju, Jia
    Liao, Xin
    Huang, Xiaoyuan
    Feng, Ling
    Ma, Ding
    He, Liang
    Chen, Dongsheng
    Chen, Gang
    Jin, Xin
    Wu, Peng
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2021, 9 (01)
  • [38] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis
    Kruse, Jan Matthias
    Magomedov, Abakar
    Kurreck, Annika
    Muench, Frederic H.
    Koerner, Roland
    Kamhieh-Milz, Julian
    Kahl, Andreas
    Gotthardt, Inka
    Piper, Sophie K.
    Eckardt, Kai-Uwe
    Doerner, Thomas
    Zickler, Daniel
    CRITICAL CARE, 2020, 24 (01)
  • [39] Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19
    Alkhateeb, Tuqa
    Stollings, Joanna L.
    Sohn, Ine
    Liu, Dandan
    Fleenor, L. Montana
    Ely, E. Wesley
    Lahiri, Shouri
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Invasiveness of Ventilation Therapy Is Associated to Prevalence of Secondary Bacterial and Fungal Infections in Critically Ill COVID-19 Patients
    de Hesselle, Marie Louise
    Borgmann, Stefan
    Rieg, Siegbert
    Vehreshild, Jorg Janne
    Spinner, Christoph D.
    Koll, Carolin E. M.
    Hower, Martin
    Stecher, Melanie
    Ebert, Daniel
    Hanses, Frank
    Schumann, Julia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)